Dr. Tseng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Fivepoint
Irvine, CA 92618Phone+1 949-671-4673
Education & Training
University of ChicagoFellowship, Complex General Surgical Oncology, 2015 - 2017
MacLean Center for Clinical Medical EthicsClinical Ethics, 2015 - 2016
Oregon Health & Science University (OHSU Health)Residency, Surgery, 2009 - 2015- National Cancer InstituteClinical Immunotherapy, 2012 - 2013
University of California, Davis, School of MedicineClass of 2009
Certifications & Licensure
OR State Medical License 2012 - Present
CA State Medical License 2022 - 2026
IL State Medical License 2015 - 2023- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 6 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-12-01 - 2 citationsDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda
Nature Medicine. 2024-12-01 - Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.Mara A Piltin, Peter Norwood, Velle Ladores, Rita A Mukhtar, Candice A Sauder
Annals of Surgical Oncology. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
